miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop

Min Deng1, Chao Zeng2, Xihong Lu3

  • 1Cancer Hospital and Cancer Research Institute, Guangzhou Medical University, Guangzhou, Guangdong Province, China.

Cancer Letters
|June 22, 2017
PubMed

Insights

MicroRNA-218 (miR-218) suppresses gastric cancer progression by inhibiting cell cycle regulators CDK6 and Cyclin D1. Reduced miR-218 correlates with poor prognosis, suggesting therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-218 (miR-218) has shown anti-tumor potential in various cancers, but its specific role in gastric cancer (GC) remains unclear.
  • Understanding miR-218's function in gastric cancer cell cycle regulation is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the regulatory mechanisms and functional impact of miR-218 on cell cycle progression in gastric cancer.
  • To elucidate the molecular targets and signaling pathways influenced by miR-218 in gastric cancer.

Main Methods:

  • Investigated miR-218's effect on gastric cancer cell proliferation, cell cycle arrest (G1 phase), and tumor growth/metastasis in vivo.
  • Utilized luciferase reporter assays and Western blotting to confirm miR-218's targeting of CDK6 and Cyclin D1.
  • Analyzed miR-218 expression levels in gastric cancer tissues and correlated them with clinical parameters.

Main Results:

  • miR-218 suppressed gastric cancer cell proliferation, induced G1 phase arrest, and inhibited tumor growth and metastasis.
  • miR-218 directly targeted CDK6 and Cyclin D1, repressing the pRb/E2F1 signaling pathway.
  • Reduced miR-218 expression in GC tissues correlated with advanced stage, metastasis, and poor prognosis.
  • A negative feedback loop was identified where E2F1 activates miR-218 expression via SLIT2/SLIT3.

Conclusions:

  • miR-218 acts as a tumor suppressor in gastric cancer by inhibiting cell cycle progression through the miR-218-CDK6/CyclinD1-E2F1 axis.
  • Disruption of this regulatory loop contributes to gastric cancer development.
  • miR-218 represents a potential therapeutic target for gastric cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
4.0K